We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Aegis Acquires Diagnovus
News

Aegis Acquires Diagnovus

Aegis Acquires Diagnovus
News

Aegis Acquires Diagnovus

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Aegis Acquires Diagnovus"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Aegis Sciences Corporation announced the acquisition of Diagnovus LLC.

“The asset acquisition of Diagnovus allows Aegis to expand our healthcare laboratory testing services,” stated Aegis Founder, Chairman and CEO Dr. David L. Black. “The delivery of patient-specific genetic information to physicians will improve management of disease and prescribing of necessary medication.”

Diagnovus has developed multiple molecular diagnostic assays, including a buccal swab test which provides insight into an individual’s response to certain medications based on genetic structure. This valuable information may increase the quality of care by reducing the time required to find the optimal course of treatment.

“As a scientist and entrepreneur, I am proud to have our team join Aegis,” stated Diagnovus President and Co-Founder Dr. James Stover. “Aegis’ reputation and client base will allow us to offer our developed molecular diagnostic testing services to a much larger patient population.”


Advertisement